Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and e supplementation

International Urology and Nephrology

Volumn 45, Issue 4, 2013, Pages 1137-1144

  Boudouris, Georgios ^a,b   Verginadis, Ioannis I ^a   Simos, Yannis V ^a   Zouridakis, Andreas ^a,c   Ragos, Vasilios ^d   Karkabounas, Spyridon Ch ^a   Evangelou, Angelos M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c General Hospital   (Greece)

^d UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

a tocopherol; Antioxidants; Ascorbic acid; Oxidative stress; Peritoneal dialysis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARBONYL DERIVATIVE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PYRIDOXINE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PERITONEAL FLUID; TREATMENT OUTCOME; URINALYSIS; VITAMIN SUPPLEMENTATION;

AGED; ANALYSIS OF VARIANCE; ASCORBIC ACID; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VITAMIN E;

EID: 84881475126     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0334-6     Document Type: Article

References (43)

1. Vanholder R, Massy Z, Argiles A et al (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20:1048-1056
2. Van Biesen W, De Bacquer D, Verbeke F et al (2007) The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 28:478-483
3. Fried LF, Shlipak MG, Crump C et al (2003) Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41:1364-1372
4. Kocak H, Gumuslu S, Ermis C et al (2008) Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol 28:91-96
5. Arima H, Nakamoto H, Okada S et al (2006) Risk factors for vascular complications in patients on peritoneal dialysis. Adv Perit Dial 22:192-197
6. Pecoits-Filho R, Lindholm B, Stenvinkel P (2002) The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 11:28-31
7. Sahin E, Göçmen AY, Koçak H (2008) The association of advanced glycation end-products with glutathione status. Ann Clin Biochem 45:369-374
8. Del Vecchio L, Locatelli F, Carini M (2011) What we know about oxidative stress in patients with chronic kidney disease on dialysis - clinical effects, potential treatment, and prevention. Semin Dial 24:56-64
9. Dursun B, Dursun E, Capraz I et al (2008) Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms? J Investig Med 56:545-552
10. Honda K, Nitta K, Horita S et al (1999) Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14:1541-1549
11. Kaneko K, Hamada C, Tomino Y (2007) Peritoneal fibrosis intervention. Perit Dial Int Suppl 2:S82-S86
12. Niwa T, Tsukushi S (2001) 3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone. Kidney Int 78:S37-S41
13. De Vriese AS, Tilton RG, Mortier S et al (2006) Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 21:2549-2555
14. Noh H, Kim JS, Han KH et al (2006) Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 69:2022-2028
15. Gotloib L (2009) Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress. Contrib Nephrol 163:35-44
16. Lonn E, Yusuf S, Hoogwerf B et al (2002) HOPE Study; MICRO-HOPE study effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25:1919-1927
17. Riccioni G, Frigiola A, Pasquale S et al (2012) Vitamin C and E consumption and coronary heart disease in men. Front Biosci (Elite Ed) 4:373-380
18. Chen AF, Chen DD, Daiber A et al (2012) Free radical biology of the cardiovascular system. Clin Sci (Lond) 123:73-91
19. Coombes JS, Fassett RG (2012) Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int 81:233-246
20. Diepeveen SH, Verhoeven GH, van der Palen J et al (2005) The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment. Clin Chim Acta 361:112-118
21. Cruz DN, Soni SS, Polanco N et al (2010) Markers of inflammation and oxidative stress in peritoneal dialysis: a comparison between high and low peritoneal transporters. J Nephrol 23:453-458
22. Charalampidis PS, Veltsistas P, Karkabounas S et al (2009) Blue CrO5 assay: a novel spectrophotometric method for the evaluation of the antioxidant and oxidant capacity of various biological substances. Eur J Med Chem 44:4162-4168
23. Hong YC, Lee KH, Yi CH et al (2002) Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett 129:255-262
24. Alamdari DH, Kostidou E, Paletas K et al (2005) High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. Free Radic Biol Med 39:1362-1367
25. Mydlík M, Derzsiová K (2004) Vitamin B6 and oxalic acid in clinical nephrology. Front Biosci 9:2901-2908
26. Handelman GJ (2000) Evaluation of oxidant stress in dialysis patients. Blood Purif 18:343-349
27. Aguilera A, Bajo MA, del Peso G et al (2002) True deficiency of antioxidant vitamins E and A in dialysis patients. Relationship with clinical patterns of atherosclerosis. Adv Perit Dial 18:206-211
28. Ece A, Gürkan F, Kervancioǧlu M et al (2006) Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 21:545-552
29. Domenici FA, Vannucchi MT, Jordão AA Jr et al (2005) DNA oxidative damage in patients with dialysis treatment. Ren Fail 27:689-694
30. Shah GM, Ross EA, Sabo A et al (1992) Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 20:42-49
31. Mydlík M, Derzsiová K, Rácz O et al (2002) Vitamin E as an antioxidant agent in CAPD patients. Int J Artif Organs 25:373-378
32. Palleschi S, De Angelis S, Diana L et al (2007) Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clin Chem Lab Med 45:1211-1218
33. Dounousi E, Papavasiliou E, Makedou A et al (2006) Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752-760
34. Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J et al (2009) Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis 3:22-27
35. Malliaraki N, Mpliamplias D, Kampa M et al (2003) Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol 4:4
36. Mitrogianni Z, Barbouti A, Galaris D et al (2009) Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract 113:c230-c234
37. Antoniades C, Tousoulis D, Tentolouris C et al (2003) Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 28:628-638
38. Mann JF, Lonn EM, Yi Q et al (2004) HOPE investigators effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int 65:1375-1380
39. Kamgar M, Zaldivar F, Vaziri ND et al (2009) Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. J Natl Med Assoc 101:336-344
40. Galli F (2007) Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant Suppl 5:v20-v36
41. Nguyen-Khoa T, Massy ZA, De Bandt JP et al (2001) Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335-340
42. Diepeveen SH, Verhoeven GW, Van Der Palen J et al (2005) Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial. J Intern Med 257:438-445
43. Piroddi M, Pilolli F, Aritomi M et al (2012) Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol 35:559-572